Stay updated with breaking news from Update Guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Although antibiotics are the standard-of-care treatment for Clostridioides difficile infection, they can cause further microbiota changes that predispose patients to recurrence.
This JAMA Patient Page summarizes the American College of Gastroenterology’s 2021 guidelines on treatment of Clostridioides difficile infection.
DIFICLIRTM (fidaxomicin) is now recommended as first-line CDI treatment in both European and U.S. guidelines1,2 Significantly fewer patients in the fidaxomicin group than the vancomycin group